Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis.
作者信息
Kanate Abraham S, DiGilio Alyssa, Ahn Kwang W, Al Malki Monzr, Jacobsen Eric, Steinberg Amir, Hamerschlak Nelson, Kharfan-Dabaja Mohamed, Salit Rachel, Ball Edward, Bashir Qaiser, Cashen Amanda, Couriel Daniel, Diez-Martin Jose, Katsanis Emmanuel, Linhares Yulia, Mori Shahram, Nash Richard, Pawarode Attaphol, Perales Miguel-Angel, Phipps Colin D, Richman Carol, Savani Bipin N, Shapira Michael Y, Stiff Patrick, Strair Roger, Fenske Timothy S, Smith Sonali M, Sureda Anna, Olteanu Horatiu, Hamadani Mehdi
机构信息
Osborn Hematopoietic Malignancy and Transplantation Program, West Virginia University, Morgantown, WV, USA.
CIBMTR (Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
出版信息
Br J Haematol. 2018 Sep;182(6):916-920. doi: 10.1111/bjh.14879. Epub 2017 Aug 2.
Abstract
摘要
相似文献
1
Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis.异基因造血细胞移植治疗鼻型结外自然杀伤/T细胞淋巴瘤：一项国际骨髓移植登记处（CIBMTR）的分析
Br J Haematol. 2018 Sep;182(6):916-920. doi: 10.1111/bjh.14879. Epub 2017 Aug 2.
2
Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center.自体造血干细胞移植可能改善新诊断的鼻型结外自然杀伤/T细胞淋巴瘤患者的长期预后：一项单中心回顾性对照研究
Int J Hematol. 2018 Jan;107(1):98-104. doi: 10.1007/s12185-017-2324-z. Epub 2017 Aug 30.
3
Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.普拉曲沙作为一线化疗难治的晚期结外鼻型自然杀伤/T细胞淋巴瘤患者异基因造血干细胞移植的桥梁：一例报告
J Med Case Rep. 2020 Mar 17;14(1):43. doi: 10.1186/s13256-020-02363-3.
4
Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/T-Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).结外鼻型自然杀伤/T 细胞淋巴瘤患者造血干细胞移植后的结局：来自法国骨髓和细胞治疗学会（SFGM-TC）的一项研究。
Am J Hematol. 2021 Jul 1;96(7):834-845. doi: 10.1002/ajh.26200. Epub 2021 May 3.
5
Comparison of Total Body Irradiation (TBI) Conditioning with Non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T- and NK-Cell Non-Hodgkin Lymphoma.全身照射（TBI）预处理与非TBI预处理在初诊或复发的成熟T细胞和NK细胞非霍奇金淋巴瘤自体干细胞移植中的比较
Cancer Res Treat. 2017 Jan;49(1):92-103. doi: 10.4143/crt.2015.476. Epub 2016 May 9.
6
[Clinical study of extranodal NK-T cell lymphoma-nasal type].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2005 Nov;40(11):850-4.
7
[Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].[鼻型结外自然杀伤/T细胞淋巴瘤的发病率及治疗。匈牙利的经验]
Orv Hetil. 2017 Oct;158(41):1635-1641. doi: 10.1556/650.2017.30871.
8
Donor lymphocyte infusion for extranodal NK/T cell lymphoma, nasal type, relapsed after allogeneic hematopoietic SCT.供体淋巴细胞输注用于鼻型结外NK/T细胞淋巴瘤，异基因造血干细胞移植后复发者。
Bone Marrow Transplant. 2011 Sep;46(9):1270-1. doi: 10.1038/bmt.2010.284. Epub 2010 Nov 8.
9
Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type.异基因造血干细胞移植治疗晚期结外鼻型自然杀伤/T 细胞淋巴瘤。
Leuk Lymphoma. 2011 Jul;52(7):1255-61. doi: 10.3109/10428194.2011.572322. Epub 2011 May 23.
10
Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type.结外 NK/T 细胞淋巴瘤，鼻型的治疗和监测进展。
Br J Haematol. 2009 Oct;147(1):13-21. doi: 10.1111/j.1365-2141.2009.07802.x. Epub 2009 Jul 7.
引用本文的文献
1
Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party.NK/T细胞淋巴瘤中的自体干细胞移植：EBV-DNA对多国队列的预后影响——欧洲血液与骨髓移植协会淋巴瘤工作组的一项研究
Hemasphere. 2025 Aug 15;9(8):e70184. doi: 10.1002/hem3.70184. eCollection 2025 Aug.
2
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up.外周T细胞和自然杀伤细胞淋巴瘤：ESMO-EHA诊断、治疗及随访临床实践指南
Hemasphere. 2025 May 7;9(5):e70128. doi: 10.1002/hem3.70128. eCollection 2025 May.
3
Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data.克服晚期或复发难治性结外NK/T细胞淋巴瘤的挑战：个体患者数据的荟萃分析
Front Oncol. 2024 Jul 31;14:1362367. doi: 10.3389/fonc.2024.1362367. eCollection 2024.
4
Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas.寥寥无几：罕见结外成熟 T 细胞和 NK 细胞淋巴瘤的临床处理方法。
Haematologica. 2023 Dec 1;108(12):3244-3260. doi: 10.3324/haematol.2023.282717.
5
A Rare Case of Aggressive Disseminated Nasal-Type Epstein-Barr Virus-Positive Extranodal Natural Killer/T-Cell Lymphoma with Bone Marrow Involvement.罕见侵袭性播散性鼻型 Epstein-Barr 病毒阳性结外自然杀伤/T 细胞淋巴瘤伴骨髓累及。
Am J Case Rep. 2023 Jun 18;24:e939286. doi: 10.12659/AJCR.939286.
6
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis.异基因造血干细胞移植治疗 NK/T 细胞淋巴瘤：国际协作分析。
Leukemia. 2023 Jul;37(7):1511-1520. doi: 10.1038/s41375-023-01924-x. Epub 2023 May 8.
7
EBV and Lymphomagenesis.爱泼斯坦-巴尔病毒与淋巴瘤发生
Cancers (Basel). 2023 Apr 4;15(7):2133. doi: 10.3390/cancers15072133.
8
How we treat NK/T-cell lymphomas.我们如何治疗 NK/T 细胞淋巴瘤。
J Hematol Oncol. 2022 Jun 3;15(1):74. doi: 10.1186/s13045-022-01293-5.
9
Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions.结外自然杀伤细胞/T细胞淋巴瘤：当前方法与未来方向
J Clin Med. 2022 May 10;11(10):2699. doi: 10.3390/jcm11102699.
10
Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies.自然杀伤细胞恶性肿瘤诊断与治疗的最新进展
Cancers (Basel). 2022 Jan 25;14(3):597. doi: 10.3390/cancers14030597.
本文引用的文献
1
Targeting CD38 in Refractory Extranodal Natural Killer Cell-T-Cell Lymphoma.靶向难治性结外自然杀伤细胞-T细胞淋巴瘤中的CD38
N Engl J Med. 2016 Oct 13;375(15):1501-1502. doi: 10.1056/NEJMc1605684.
2
Diagnosis and management of extranodal NK/T cell lymphoma nasal type.结外 NK/T 细胞淋巴瘤鼻型的诊断与治疗。
Expert Rev Hematol. 2016 Sep;9(9):861-71. doi: 10.1080/17474086.2016.1206465. Epub 2016 Jul 8.
3
Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.鼻型结外自然杀伤/T细胞淋巴瘤初次治疗结束后基于PET-CT的Deauville评分及EB病毒DNA状态进行风险分层：一项多中心回顾性分析
Lancet Haematol. 2015 Feb;2(2):e66-74. doi: 10.1016/S2352-3026(15)00002-2. Epub 2015 Jan 28.
4
How I treat NK/T-cell lymphomas.我如何治疗 NK/T 细胞淋巴瘤。
Blood. 2013 Jun 20;121(25):4997-5005. doi: 10.1182/blood-2013-01-453233. Epub 2013 May 7.
5
Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma.自然杀伤/T 细胞淋巴瘤中鉴定出的 Janus 激酶 3 激活突变。
Cancer Discov. 2012 Jul;2(7):591-7. doi: 10.1158/2159-8290.CD-12-0028. Epub 2012 Jun 15.
6
Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.治疗晚期结外 NK/T 细胞淋巴瘤，鼻型和侵袭性 NK 细胞白血病。
Int J Hematol. 2010 Dec;92(5):697-701. doi: 10.1007/s12185-010-0726-2. Epub 2010 Dec 1.
7
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.自然杀伤细胞淋巴瘤与一组非肝脾 γδ T 细胞淋巴瘤具有惊人相似的分子特征，并且对新型极光激酶 A 抑制剂在体外具有高度敏感性。
Leukemia. 2011 Feb;25(2):348-58. doi: 10.1038/leu.2010.255. Epub 2010 Nov 5.
8
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project.鼻型与鼻外型自然杀伤/T细胞淋巴瘤的临床差异：一项来自国际外周T细胞淋巴瘤项目的136例病例研究。
Blood. 2009 Apr 23;113(17):3931-7. doi: 10.1182/blood-2008-10-185256. Epub 2008 Nov 24.
9
Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms.异基因造血干细胞移植作为自然杀伤细胞肿瘤的一种有前景的治疗方法。
Br J Haematol. 2005 Aug;130(4):561-7. doi: 10.1111/j.1365-2141.2005.05651.x.
Zotero 插件